• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / The protocol of a randomized, double-blinded, placebo controlled trial to investigate the role of intra-peritoneal ropivacaine in gastric bypass surgery

The protocol of a randomized, double-blinded, placebo controlled trial to investigate the role of intra-peritoneal ropivacaine in gastric bypass surgery

Robert Wu, Alexis Porte, Fatima Haggar, Isabelle Raiche, Husein Moloo, Jean Claude Gauthier, Amy Neville, Jean Denis Yelle, Joseph Mamazza. The Ottawa Hospital, University of Ottawa.

Introduction
Postoperative pain control remains a major challenge, even in laparoscopic surgery such as gastric bypass. Effective pain control reduces the risk of postoperative complication such as deep vein thrombosis and pulmonary emboli, pulmonary morbidity (eg. atelectasis and pneumonia), and tachycardia. Pain management is especially important in obese patients who may have a number of cardiovascular and pulmonary comorbidities that increase perioperative risk. These include a high prevalence of obstructive sleep apnea, hypoxia and respiratory depression. The objective of this study is to evaluate the efficacy of intraperitoneal local anesthetic (IPLA), in this case Ropivicaine, to reduce post-operative pain in patients undergoing laparoscopic Roux-en-Y gastric bypass surgery (LRYGB). We hypothesize that the use of IPLA will lead to a decrease in early postoperative pain and improvements in other clinically important postoperative outcomes and quality of life (QoL) in the period shortly after the surgery.

Methods and Procedures
A single-centre, double blinded, randomised controlled trial will be conducted to compare intraperitoneal ropivacaine (intervention) versus normal saline (placebo) in 120 adult patients undergoing LRYGB. After penumoperitoneum establishment, 200mg of Ropivacaine (0.2% Ropivacaine in 100 mL Normal Saline) will be instilled in the abdomen at the start of the case before surgical dissection. Under direct visualization, 50 mL will be infused over the esophageal hiatus. The remaining 50 mL will be infused throughout the abdomen. Patients in the control group will undergo the same treatment with normal saline. Standardized doses of local anesthesia will be used at the incision sites for all patients. All patients will be cared for by our standard bariatric post-operative protocol and discharged when criteria are met. Patients will be followed until their first follow-up clinic within 10 days of discharge.
Primary endpoint will be post-operative pain measured by the visual analogue scale (VAS). VAS pain score will be measured at baseline preoperatively, in recovery room, at 1, 2, and 4 hours post-operatively. Pain measurement will continue every 4 hours for a period of 24 hours and every 8 hours for up to 48 hours if the patients remain in hospital that long. Secondary endpoints will include opioid use, peak expiratory flow score, 6-minute walk distance, and quality of life assessed by the Quality of Recovery instrument (QR40) in the immediate post-operative period.

Conclusion
The study, regardless of its findings, will have an impact on use of (IPLA) in laparoscopic gastric bypass surgery.  A positive finding would confirm the effectiveness of IPLA in laparoscopic gastric bypass surgery.  Negative results may lead to changes to the current postoperative management practices and prompt further research to improve pain management following laparoscopic gastric bypass.

View Poster

63

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals